Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
7.26B
Market cap7.26B
Price-Earnings ratio
-40.12
Price-Earnings ratio-40.12
Dividend yield
Dividend yield
Average volume
976.98K
Average volume976.98K
High today
$160.26
High today$160.26
Low today
$149.98
Low today$149.98
Open price
$158.26
Open price$158.26
Volume
1.28M
Volume1.28M
52 Week high
$228.88
52 Week high$228.88
52 Week low
$132.58
52 Week low$132.58

Stock Snapshot

The current Charles River(CRL) stock price is $150.85, with a market capitalization of 7.26B. The stock trades at a price-to-earnings (P/E) ratio of -40.12.

As of 2026-05-16, Charles River(CRL) stock has fluctuated between $149.98 and $160.26. The current price stands at $150.85, placing the stock +0.6% above today's low and -5.9% off the high.

Charles River(CRL) shares are trading with a volume of 1.28M, against a daily average of 976.98K.

In the last year, Charles River(CRL) shares hit a 52-week high of $228.88 and a 52-week low of $132.58.

In the last year, Charles River(CRL) shares hit a 52-week high of $228.88 and a 52-week low of $132.58.

CRL News

Simply Wall St 18h
Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform

Charles River Laboratories International (NYSE:CRL) has entered into a partnership with MEDIPOST to support development and commercialization of cell therapies...

Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform
TipRanks 3d
Charles River, Medipost sign non-exclusive MoU to advance GMP testing solutions

Charles River (CRL) Laboratories and Medipost have entered into a strategic, non-exclusive Memorandum of Understanding to collaborate on GMP-compliant testing,...

TipRanks 5d
Charles River Labs Shareholders Approve New Incentive Plan

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

63%

of 19 ratings
Buy
63.2%
Hold
36.8%
Sell
0%

More CRL News

TipRanks 5d
Charles River announces ‘continued momentum’ in digital pathology platform

Charles River (CRL) Laboratories International announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow tha...

TipRanks 6d
Charles River Labs: Buy Rating Reiterated as 2026 Outlook Strengthens; $235 Price Target Maintained

Analyst Charles Rhyee of TD Cowen maintained a Buy rating on Charles River Labs, retaining the price target of $235.00. Claim 55% Off TipRanks Unlock hedge fund...

Simply Wall St 7d
A Look At Charles River Laboratories Valuation After Recent Share Price Momentum

Charles River Laboratories International (CRL) is back on investor radars after recent share price moves, with the stock near US$181 and mixed returns across th...

A Look At Charles River Laboratories Valuation After Recent Share Price Momentum

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.